Correction to: Population Pharmacokinetic Evaluation of Amikacin Liposome Inhalation Suspension in Patients with Treatment‑Refractory Nontuberculous Mycobacterial Lung Disease
Eur J Drug Metab Pharmacokinet. 2021 Jul;46(4):573-574.
doi: 10.1007/s13318-021-00687-z.
1 Institute for Clinical Pharmacodynamics, Inc, 242 Broadway, Schenectady, NY, USA. [email protected].
2 Institute for Clinical Pharmacodynamics, Inc, 242 Broadway, Schenectady, NY, USA.
3 Department of Medical Microbiology, Radboudumc Center for Infectious Diseases, Radboud University Medical Center, Geert Grooteplein 10, 6525 GA, Nijmegen, The Netherlands.
4 The University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, TX, USA.
5 National Jewish Health, 1400 Jackson St, Denver, CO, 80206, USA.
6 Insmed Incorporated, 700 US-206, Bridgewater, NJ, USA.
7 Oregon Health and Science University, 3375 SW Terwilliger Boulevard, Portland, OR, USA.